nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—hematologic cancer	0.351	1	CbGaD
Gadoxetate—ABCC4—Tioguanine—hematologic cancer	0.0941	0.226	CbGbCtD
Gadoxetate—ABCC4—Mercaptopurine—hematologic cancer	0.0391	0.0939	CbGbCtD
Gadoxetate—ABCC2—Daunorubicin—hematologic cancer	0.03	0.0721	CbGbCtD
Gadoxetate—ABCC3—Vincristine—hematologic cancer	0.0276	0.0663	CbGbCtD
Gadoxetate—ABCC3—Cisplatin—hematologic cancer	0.0258	0.0619	CbGbCtD
Gadoxetate—ABCC3—Etoposide—hematologic cancer	0.0253	0.0608	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—hematologic cancer	0.0173	0.0415	CbGbCtD
Gadoxetate—ABCC3—Methotrexate—hematologic cancer	0.0167	0.0402	CbGbCtD
Gadoxetate—SLCO1B1—Irinotecan—hematologic cancer	0.0163	0.0393	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—hematologic cancer	0.0148	0.0357	CbGbCtD
Gadoxetate—ABCC2—Irinotecan—hematologic cancer	0.0144	0.0345	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—hematologic cancer	0.0128	0.0307	CbGbCtD
Gadoxetate—ABCC2—Vinblastine—hematologic cancer	0.0128	0.0307	CbGbCtD
Gadoxetate—ABCC2—Vincristine—hematologic cancer	0.0125	0.0302	CbGbCtD
Gadoxetate—ABCC2—Cisplatin—hematologic cancer	0.0117	0.0281	CbGbCtD
Gadoxetate—ABCC2—Etoposide—hematologic cancer	0.0115	0.0276	CbGbCtD
Gadoxetate—ABCC2—Dexamethasone—hematologic cancer	0.00945	0.0227	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—hematologic cancer	0.00865	0.0208	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—hematologic cancer	0.00784	0.0188	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—hematologic cancer	0.0076	0.0183	CbGbCtD
Gadoxetate—SLCO1B3—lung—hematologic cancer	0.000899	0.101	CbGeAlD
Gadoxetate—SLCO1B1—hematopoietic system—hematologic cancer	0.000895	0.101	CbGeAlD
Gadoxetate—ABCC3—hematopoietic system—hematologic cancer	0.000849	0.0957	CbGeAlD
Gadoxetate—ABCC4—hematopoietic system—hematologic cancer	0.000701	0.079	CbGeAlD
Gadoxetate—SLCO1B1—blood—hematologic cancer	0.000593	0.0668	CbGeAlD
Gadoxetate—Gadofosveset trisodium—ALB—hematologic cancer	0.000589	1	CrCbGaD
Gadoxetate—ABCC3—blood—hematologic cancer	0.000563	0.0634	CbGeAlD
Gadoxetate—ABCC3—lung—hematologic cancer	0.000493	0.0556	CbGeAlD
Gadoxetate—ABCC3—testis—hematologic cancer	0.000465	0.0525	CbGeAlD
Gadoxetate—ABCC4—blood—hematologic cancer	0.000464	0.0523	CbGeAlD
Gadoxetate—ABCC2—blood—hematologic cancer	0.00045	0.0507	CbGeAlD
Gadoxetate—ABCC4—bone marrow—hematologic cancer	0.000449	0.0507	CbGeAlD
Gadoxetate—ABCC4—lung—hematologic cancer	0.000407	0.0459	CbGeAlD
Gadoxetate—ABCC4—testis—hematologic cancer	0.000384	0.0433	CbGeAlD
Gadoxetate—ABCC2—testis—hematologic cancer	0.000372	0.0419	CbGeAlD
Gadoxetate—ABCC3—lymph node—hematologic cancer	0.000337	0.038	CbGeAlD
Gadoxetate—ABCC4—lymph node—hematologic cancer	0.000278	0.0314	CbGeAlD
Gadoxetate—ABCC2—lymph node—hematologic cancer	0.00027	0.0304	CbGeAlD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.69e-05	0.000557	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RASGRP1—hematologic cancer	2.67e-05	0.000553	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.67e-05	0.000553	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SYK—hematologic cancer	2.66e-05	0.000552	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—FHL2—hematologic cancer	2.66e-05	0.000551	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.65e-05	0.00055	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.61e-05	0.000542	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AGRN—hematologic cancer	2.61e-05	0.00054	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.6e-05	0.000539	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	2.6e-05	0.000538	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HDC—hematologic cancer	2.58e-05	0.000534	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA2—hematologic cancer	2.55e-05	0.000529	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—hematologic cancer	2.54e-05	0.000527	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.52e-05	0.000523	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	2.52e-05	0.000523	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—hematologic cancer	2.51e-05	0.00052	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.51e-05	0.000519	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMMR—hematologic cancer	2.47e-05	0.000512	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—IDH2—hematologic cancer	2.47e-05	0.000512	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.47e-05	0.000511	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.46e-05	0.000509	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GRB2—hematologic cancer	2.4e-05	0.000498	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.4e-05	0.000498	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—FHL2—hematologic cancer	2.4e-05	0.000497	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PDGFA—hematologic cancer	2.4e-05	0.000496	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	2.4e-05	0.000496	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—hematologic cancer	2.39e-05	0.000495	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CDA—hematologic cancer	2.36e-05	0.000488	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AGRN—hematologic cancer	2.35e-05	0.000487	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.33e-05	0.000483	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.33e-05	0.000483	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ARNTL—hematologic cancer	2.32e-05	0.000481	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.32e-05	0.000481	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ABL1—hematologic cancer	2.31e-05	0.000478	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.28e-05	0.000473	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PC—hematologic cancer	2.27e-05	0.00047	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA9—hematologic cancer	2.26e-05	0.000468	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ACP5—hematologic cancer	2.26e-05	0.000468	CbGpPWpGaD
Gadoxetate—Headache—Gemcitabine—hematologic cancer	2.26e-05	0.000129	CcSEcCtD
Gadoxetate—Nausea—Vincristine—hematologic cancer	2.25e-05	0.000129	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—hematologic cancer	2.25e-05	0.000129	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—hematologic cancer	2.25e-05	0.000129	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—hematologic cancer	2.25e-05	0.000129	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisolone—hematologic cancer	2.23e-05	0.000128	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—hematologic cancer	2.23e-05	0.000128	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—NCOR2—hematologic cancer	2.23e-05	0.000462	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—IDH2—hematologic cancer	2.23e-05	0.000462	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMMR—hematologic cancer	2.23e-05	0.000462	CbGpPWpGaD
Gadoxetate—Urticaria—Triamcinolone—hematologic cancer	2.22e-05	0.000127	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—hematologic cancer	2.21e-05	0.000127	CcSEcCtD
Gadoxetate—Asthenia—Etoposide—hematologic cancer	2.21e-05	0.000126	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—hematologic cancer	2.21e-05	0.000126	CcSEcCtD
Gadoxetate—Body temperature increased—Triamcinolone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Oedema—Prednisone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—hematologic cancer	2.2e-05	0.000456	CbGpPWpGaD
Gadoxetate—Decreased appetite—Betamethasone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Decreased appetite—Dexamethasone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Nausea—Mitoxantrone—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Nausea—Irinotecan—hematologic cancer	2.2e-05	0.000126	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—hematologic cancer	2.19e-05	0.000126	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—SLC35B2—hematologic cancer	2.19e-05	0.000454	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GBA—hematologic cancer	2.19e-05	0.000454	CbGpPWpGaD
Gadoxetate—Infection—Prednisone—hematologic cancer	2.19e-05	0.000125	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.19e-05	0.000454	CbGpPWpGaD
Gadoxetate—Mediastinal disorder—Epirubicin—hematologic cancer	2.19e-05	0.000125	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—Fatigue—Betamethasone—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—Fatigue—Dexamethasone—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—Chills—Epirubicin—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—hematologic cancer	2.18e-05	0.000125	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—HGF—hematologic cancer	2.17e-05	0.00045	CbGpPWpGaD
Gadoxetate—Shock—Prednisone—hematologic cancer	2.17e-05	0.000124	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—hematologic cancer	2.17e-05	0.000124	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—hematologic cancer	2.16e-05	0.000124	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—hematologic cancer	2.15e-05	0.000123	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—CSF2—hematologic cancer	2.15e-05	0.000445	CbGpPWpGaD
Gadoxetate—Skin disorder—Prednisone—hematologic cancer	2.14e-05	0.000123	CcSEcCtD
Gadoxetate—Nausea—Gemcitabine—hematologic cancer	2.14e-05	0.000123	CcSEcCtD
Gadoxetate—Vomiting—Cisplatin—hematologic cancer	2.13e-05	0.000122	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisone—hematologic cancer	2.13e-05	0.000122	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—hematologic cancer	2.13e-05	0.000122	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—IDH1—hematologic cancer	2.12e-05	0.00044	CbGpPWpGaD
Gadoxetate—Rash—Cisplatin—hematologic cancer	2.12e-05	0.000121	CcSEcCtD
Gadoxetate—Dermatitis—Cisplatin—hematologic cancer	2.11e-05	0.000121	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—hematologic cancer	2.1e-05	0.000121	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.1e-05	0.000435	CbGpPWpGaD
Gadoxetate—Anorexia—Prednisone—hematologic cancer	2.1e-05	0.00012	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—TXN—hematologic cancer	2.1e-05	0.000435	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCC3—hematologic cancer	2.1e-05	0.000435	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTO1—hematologic cancer	2.1e-05	0.000435	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ARNTL—hematologic cancer	2.1e-05	0.000434	CbGpPWpGaD
Gadoxetate—Ill-defined disorder—Methotrexate—hematologic cancer	2.09e-05	0.00012	CcSEcCtD
Gadoxetate—Feeling abnormal—Dexamethasone—hematologic cancer	2.09e-05	0.000119	CcSEcCtD
Gadoxetate—Feeling abnormal—Betamethasone—hematologic cancer	2.09e-05	0.000119	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—hematologic cancer	2.08e-05	0.000119	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—hematologic cancer	2.08e-05	0.000119	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—hematologic cancer	2.08e-05	0.000119	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—JAK1—hematologic cancer	2.07e-05	0.000429	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PRKCG—hematologic cancer	2.07e-05	0.000429	CbGpPWpGaD
Gadoxetate—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.07e-05	0.000119	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Betamethasone—hematologic cancer	2.07e-05	0.000119	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—hematologic cancer	2.07e-05	0.000118	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.06e-05	0.000427	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SPHK1—hematologic cancer	2.06e-05	0.000426	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Triamcinolone—hematologic cancer	2.05e-05	0.000118	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—hematologic cancer	2.04e-05	0.000117	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—CA9—hematologic cancer	2.04e-05	0.000422	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ACP5—hematologic cancer	2.04e-05	0.000422	CbGpPWpGaD
Gadoxetate—Angiopathy—Doxorubicin—hematologic cancer	2.04e-05	0.000117	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—hematologic cancer	2.03e-05	0.000117	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—hematologic cancer	2.03e-05	0.000116	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—hematologic cancer	2.03e-05	0.000116	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—hematologic cancer	2.03e-05	0.000116	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—hematologic cancer	2.02e-05	0.000116	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	2.02e-05	0.000418	CbGpPWpGaD
Gadoxetate—Chills—Doxorubicin—hematologic cancer	2.01e-05	0.000115	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—NCOR2—hematologic cancer	2.01e-05	0.000417	CbGpPWpGaD
Gadoxetate—Urticaria—Betamethasone—hematologic cancer	2.01e-05	0.000115	CcSEcCtD
Gadoxetate—Urticaria—Dexamethasone—hematologic cancer	2.01e-05	0.000115	CcSEcCtD
Gadoxetate—Dizziness—Prednisolone—hematologic cancer	2.01e-05	0.000115	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—hematologic cancer	2.01e-05	0.000115	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—MTAP—hematologic cancer	2e-05	0.000415	CbGpPWpGaD
Gadoxetate—Asthenia—Triamcinolone—hematologic cancer	2e-05	0.000115	CcSEcCtD
Gadoxetate—Body temperature increased—Betamethasone—hematologic cancer	2e-05	0.000115	CcSEcCtD
Gadoxetate—Abdominal pain—Betamethasone—hematologic cancer	2e-05	0.000115	CcSEcCtD
Gadoxetate—Body temperature increased—Dexamethasone—hematologic cancer	2e-05	0.000115	CcSEcCtD
Gadoxetate—Abdominal pain—Dexamethasone—hematologic cancer	2e-05	0.000115	CcSEcCtD
Gadoxetate—Nausea—Cisplatin—hematologic cancer	1.99e-05	0.000114	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—hematologic cancer	1.99e-05	0.000114	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—hematologic cancer	1.98e-05	0.000113	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—UGT1A1—hematologic cancer	1.97e-05	0.000409	CbGpPWpGaD
Gadoxetate—Pruritus—Triamcinolone—hematologic cancer	1.97e-05	0.000113	CcSEcCtD
Gadoxetate—Cough—Methotrexate—hematologic cancer	1.97e-05	0.000113	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—hematologic cancer	1.96e-05	0.000112	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.96e-05	0.000405	CbGpPWpGaD
Gadoxetate—Convulsion—Methotrexate—hematologic cancer	1.96e-05	0.000112	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—hematologic cancer	1.95e-05	0.000112	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—hematologic cancer	1.94e-05	0.000111	CcSEcCtD
Gadoxetate—Rash—Etoposide—hematologic cancer	1.94e-05	0.000111	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—hematologic cancer	1.94e-05	0.000111	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.94e-05	0.000401	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2RA—hematologic cancer	1.93e-05	0.000401	CbGpPWpGaD
Gadoxetate—Headache—Etoposide—hematologic cancer	1.93e-05	0.00011	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—hematologic cancer	1.93e-05	0.00011	CcSEcCtD
Gadoxetate—Chest pain—Methotrexate—hematologic cancer	1.92e-05	0.00011	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—SLC22A1—hematologic cancer	1.92e-05	0.000398	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CRABP1—hematologic cancer	1.92e-05	0.000398	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.92e-05	0.000398	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—IDH1—hematologic cancer	1.92e-05	0.000397	CbGpPWpGaD
Gadoxetate—Decreased appetite—Prednisone—hematologic cancer	1.92e-05	0.00011	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—hematologic cancer	1.91e-05	0.00011	CcSEcCtD
Gadoxetate—Rash—Prednisolone—hematologic cancer	1.91e-05	0.00011	CcSEcCtD
Gadoxetate—Dermatitis—Prednisolone—hematologic cancer	1.91e-05	0.000109	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.91e-05	0.000109	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—hematologic cancer	1.9e-05	0.000109	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—hematologic cancer	1.9e-05	0.000109	CcSEcCtD
Gadoxetate—Headache—Prednisolone—hematologic cancer	1.9e-05	0.000109	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—hematologic cancer	1.9e-05	0.000109	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—hematologic cancer	1.9e-05	0.000109	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—GSTO1—hematologic cancer	1.89e-05	0.000393	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TXN—hematologic cancer	1.89e-05	0.000393	CbGpPWpGaD
Gadoxetate—Syncope—Epirubicin—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—hematologic cancer	1.89e-05	0.000108	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.89e-05	0.000391	CbGpPWpGaD
Gadoxetate—Constipation—Prednisone—hematologic cancer	1.88e-05	0.000108	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ALOX5—hematologic cancer	1.87e-05	0.000388	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.87e-05	0.000387	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PDGFB—hematologic cancer	1.87e-05	0.000387	CbGpPWpGaD
Gadoxetate—Palpitations—Epirubicin—hematologic cancer	1.87e-05	0.000107	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—hematologic cancer	1.86e-05	0.000106	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—SPHK1—hematologic cancer	1.85e-05	0.000384	CbGpPWpGaD
Gadoxetate—Dizziness—Triamcinolone—hematologic cancer	1.84e-05	0.000106	CcSEcCtD
Gadoxetate—Cough—Epirubicin—hematologic cancer	1.84e-05	0.000106	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—hematologic cancer	1.84e-05	0.000105	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—hematologic cancer	1.84e-05	0.000105	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.84e-05	0.000381	CbGpPWpGaD
Gadoxetate—Convulsion—Epirubicin—hematologic cancer	1.83e-05	0.000105	CcSEcCtD
Gadoxetate—Infection—Methotrexate—hematologic cancer	1.83e-05	0.000105	CcSEcCtD
Gadoxetate—Nausea—Etoposide—hematologic cancer	1.83e-05	0.000105	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisone—hematologic cancer	1.82e-05	0.000104	CcSEcCtD
Gadoxetate—Asthenia—Betamethasone—hematologic cancer	1.82e-05	0.000104	CcSEcCtD
Gadoxetate—Asthenia—Dexamethasone—hematologic cancer	1.82e-05	0.000104	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—hematologic cancer	1.81e-05	0.000104	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—NUP98—hematologic cancer	1.81e-05	0.000376	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CDK2—hematologic cancer	1.81e-05	0.000375	CbGpPWpGaD
Gadoxetate—Nervous system disorder—Methotrexate—hematologic cancer	1.81e-05	0.000103	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—hematologic cancer	1.8e-05	0.000103	CcSEcCtD
Gadoxetate—Nausea—Prednisolone—hematologic cancer	1.8e-05	0.000103	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—hematologic cancer	1.8e-05	0.000103	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—hematologic cancer	1.8e-05	0.000103	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—hematologic cancer	1.79e-05	0.000103	CcSEcCtD
Gadoxetate—Pruritus—Betamethasone—hematologic cancer	1.79e-05	0.000103	CcSEcCtD
Gadoxetate—Pruritus—Dexamethasone—hematologic cancer	1.79e-05	0.000103	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—FHL2—hematologic cancer	1.78e-05	0.00037	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—UGT1A1—hematologic cancer	1.78e-05	0.000369	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Methotrexate—hematologic cancer	1.78e-05	0.000102	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—hematologic cancer	1.78e-05	0.000102	CcSEcCtD
Gadoxetate—Vomiting—Triamcinolone—hematologic cancer	1.77e-05	0.000102	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.77e-05	0.000367	CbGpPWpGaD
Gadoxetate—Malaise—Doxorubicin—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ADCY7—hematologic cancer	1.76e-05	0.000365	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NCOA3—hematologic cancer	1.76e-05	0.000365	CbGpPWpGaD
Gadoxetate—Rash—Triamcinolone—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Gadoxetate—Dermatitis—Triamcinolone—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—hematologic cancer	1.76e-05	0.000101	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—hematologic cancer	1.75e-05	0.0001	CcSEcCtD
Gadoxetate—Urticaria—Prednisone—hematologic cancer	1.75e-05	0.0001	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—AGRN—hematologic cancer	1.75e-05	0.000363	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NUP214—hematologic cancer	1.75e-05	0.000362	CbGpPWpGaD
Gadoxetate—Headache—Triamcinolone—hematologic cancer	1.75e-05	0.0001	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—hematologic cancer	1.74e-05	9.98e-05	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—hematologic cancer	1.74e-05	9.98e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—MAPK14—hematologic cancer	1.74e-05	0.00036	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC22A1—hematologic cancer	1.73e-05	0.000359	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CRABP1—hematologic cancer	1.73e-05	0.000359	CbGpPWpGaD
Gadoxetate—Diarrhoea—Dexamethasone—hematologic cancer	1.73e-05	9.92e-05	CcSEcCtD
Gadoxetate—Diarrhoea—Betamethasone—hematologic cancer	1.73e-05	9.92e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.73e-05	0.000358	CbGpPWpGaD
Gadoxetate—Palpitations—Doxorubicin—hematologic cancer	1.73e-05	9.89e-05	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—hematologic cancer	1.72e-05	9.87e-05	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—hematologic cancer	1.72e-05	9.87e-05	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—hematologic cancer	1.72e-05	9.86e-05	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—hematologic cancer	1.72e-05	9.84e-05	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.72e-05	0.000356	CbGpPWpGaD
Gadoxetate—Infection—Epirubicin—hematologic cancer	1.71e-05	9.81e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—MTR—hematologic cancer	1.71e-05	0.000355	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCG2—hematologic cancer	1.71e-05	0.000355	CbGpPWpGaD
Gadoxetate—Cough—Doxorubicin—hematologic cancer	1.71e-05	9.77e-05	CcSEcCtD
Gadoxetate—Shock—Epirubicin—hematologic cancer	1.7e-05	9.71e-05	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—hematologic cancer	1.69e-05	9.7e-05	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—hematologic cancer	1.69e-05	9.68e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—ALOX5—hematologic cancer	1.69e-05	0.00035	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—FN1—hematologic cancer	1.68e-05	0.000349	CbGpPWpGaD
Gadoxetate—Tachycardia—Epirubicin—hematologic cancer	1.68e-05	9.64e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ENO2—hematologic cancer	1.68e-05	0.000348	CbGpPWpGaD
Gadoxetate—Skin disorder—Epirubicin—hematologic cancer	1.67e-05	9.59e-05	CcSEcCtD
Gadoxetate—Dizziness—Dexamethasone—hematologic cancer	1.67e-05	9.58e-05	CcSEcCtD
Gadoxetate—Dizziness—Betamethasone—hematologic cancer	1.67e-05	9.58e-05	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—hematologic cancer	1.67e-05	9.54e-05	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—hematologic cancer	1.66e-05	9.53e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—HMMR—hematologic cancer	1.66e-05	0.000344	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—IDH2—hematologic cancer	1.66e-05	0.000344	CbGpPWpGaD
Gadoxetate—Anxiety—Doxorubicin—hematologic cancer	1.66e-05	9.5e-05	CcSEcCtD
Gadoxetate—Nausea—Triamcinolone—hematologic cancer	1.66e-05	9.49e-05	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—hematologic cancer	1.65e-05	9.47e-05	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.65e-05	9.46e-05	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—hematologic cancer	1.64e-05	9.41e-05	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—hematologic cancer	1.64e-05	9.41e-05	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—hematologic cancer	1.64e-05	9.41e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—NUP98—hematologic cancer	1.64e-05	0.000339	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.63e-05	0.000338	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTT1—hematologic cancer	1.63e-05	0.000337	CbGpPWpGaD
Gadoxetate—Dry mouth—Doxorubicin—hematologic cancer	1.63e-05	9.32e-05	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisone—hematologic cancer	1.62e-05	9.3e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—hematologic cancer	1.61e-05	0.000334	CbGpPWpGaD
Gadoxetate—Hypotension—Epirubicin—hematologic cancer	1.61e-05	9.22e-05	CcSEcCtD
Gadoxetate—Vomiting—Betamethasone—hematologic cancer	1.61e-05	9.22e-05	CcSEcCtD
Gadoxetate—Vomiting—Dexamethasone—hematologic cancer	1.61e-05	9.22e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.6e-05	0.000332	CbGpPWpGaD
Gadoxetate—Decreased appetite—Methotrexate—hematologic cancer	1.6e-05	9.17e-05	CcSEcCtD
Gadoxetate—Rash—Dexamethasone—hematologic cancer	1.6e-05	9.14e-05	CcSEcCtD
Gadoxetate—Rash—Betamethasone—hematologic cancer	1.6e-05	9.14e-05	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—hematologic cancer	1.59e-05	9.13e-05	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—hematologic cancer	1.59e-05	9.13e-05	CcSEcCtD
Gadoxetate—Dermatitis—Dexamethasone—hematologic cancer	1.59e-05	9.13e-05	CcSEcCtD
Gadoxetate—Dermatitis—Betamethasone—hematologic cancer	1.59e-05	9.13e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—SDC1—hematologic cancer	1.59e-05	0.00033	CbGpPWpGaD
Gadoxetate—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.59e-05	9.11e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—ADCY7—hematologic cancer	1.59e-05	0.000329	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NCOA3—hematologic cancer	1.59e-05	0.000329	CbGpPWpGaD
Gadoxetate—Fatigue—Methotrexate—hematologic cancer	1.59e-05	9.1e-05	CcSEcCtD
Gadoxetate—Headache—Dexamethasone—hematologic cancer	1.59e-05	9.08e-05	CcSEcCtD
Gadoxetate—Headache—Betamethasone—hematologic cancer	1.59e-05	9.08e-05	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—hematologic cancer	1.58e-05	9.07e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PTPN11—hematologic cancer	1.58e-05	0.000328	CbGpPWpGaD
Gadoxetate—Asthenia—Prednisone—hematologic cancer	1.58e-05	9.06e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—NUP214—hematologic cancer	1.58e-05	0.000327	CbGpPWpGaD
Gadoxetate—Shock—Doxorubicin—hematologic cancer	1.57e-05	8.99e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.56e-05	0.000324	CbGpPWpGaD
Gadoxetate—Nervous system disorder—Doxorubicin—hematologic cancer	1.56e-05	8.96e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.56e-05	0.000323	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ARNTL—hematologic cancer	1.56e-05	0.000323	CbGpPWpGaD
Gadoxetate—Pruritus—Prednisone—hematologic cancer	1.56e-05	8.93e-05	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—hematologic cancer	1.56e-05	8.92e-05	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—hematologic cancer	1.55e-05	8.87e-05	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—hematologic cancer	1.55e-05	8.86e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—ABCG2—hematologic cancer	1.54e-05	0.00032	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTR—hematologic cancer	1.54e-05	0.00032	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Doxorubicin—hematologic cancer	1.54e-05	8.83e-05	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—hematologic cancer	1.54e-05	8.8e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.53e-05	0.000318	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.52e-05	0.000316	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.52e-05	0.000315	CbGpPWpGaD
Gadoxetate—Anorexia—Doxorubicin—hematologic cancer	1.52e-05	8.71e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—CA9—hematologic cancer	1.52e-05	0.000315	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ACP5—hematologic cancer	1.52e-05	0.000315	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Methotrexate—hematologic cancer	1.52e-05	8.69e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—ENO2—hematologic cancer	1.51e-05	0.000314	CbGpPWpGaD
Gadoxetate—Diarrhoea—Prednisone—hematologic cancer	1.51e-05	8.64e-05	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.51e-05	8.63e-05	CcSEcCtD
Gadoxetate—Nausea—Betamethasone—hematologic cancer	1.5e-05	8.61e-05	CcSEcCtD
Gadoxetate—Nausea—Dexamethasone—hematologic cancer	1.5e-05	8.61e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.5e-05	0.000311	CbGpPWpGaD
Gadoxetate—Decreased appetite—Epirubicin—hematologic cancer	1.5e-05	8.58e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—NCOR2—hematologic cancer	1.5e-05	0.00031	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CREBBP—hematologic cancer	1.49e-05	0.00031	CbGpPWpGaD
Gadoxetate—Hypotension—Doxorubicin—hematologic cancer	1.49e-05	8.54e-05	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.49e-05	8.52e-05	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—hematologic cancer	1.49e-05	8.51e-05	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—hematologic cancer	1.47e-05	8.44e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—GSTT1—hematologic cancer	1.47e-05	0.000304	CbGpPWpGaD
Gadoxetate—Urticaria—Methotrexate—hematologic cancer	1.46e-05	8.38e-05	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	1.46e-05	0.000303	CbGpPWpGaD
Gadoxetate—Dizziness—Prednisone—hematologic cancer	1.46e-05	8.35e-05	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—hematologic cancer	1.46e-05	8.34e-05	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—hematologic cancer	1.46e-05	8.34e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.45e-05	0.0003	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SDC1—hematologic cancer	1.44e-05	0.000298	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.44e-05	0.000297	CbGpPWpGaD
Gadoxetate—Paraesthesia—Doxorubicin—hematologic cancer	1.43e-05	8.2e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.43e-05	0.000296	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—IDH1—hematologic cancer	1.43e-05	0.000296	CbGpPWpGaD
Gadoxetate—Dyspnoea—Doxorubicin—hematologic cancer	1.42e-05	8.14e-05	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—hematologic cancer	1.42e-05	8.14e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—hematologic cancer	1.42e-05	0.000294	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTO1—hematologic cancer	1.41e-05	0.000292	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TXN—hematologic cancer	1.41e-05	0.000292	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCC3—hematologic cancer	1.41e-05	0.000292	CbGpPWpGaD
Gadoxetate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.41e-05	8.07e-05	CcSEcCtD
Gadoxetate—Vomiting—Prednisone—hematologic cancer	1.4e-05	8.03e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—ALB—hematologic cancer	1.4e-05	0.00029	CbGpPWpGaD
Gadoxetate—Rash—Prednisone—hematologic cancer	1.39e-05	7.96e-05	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—hematologic cancer	1.39e-05	7.95e-05	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—hematologic cancer	1.39e-05	7.94e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—SPHK1—hematologic cancer	1.38e-05	0.000286	CbGpPWpGaD
Gadoxetate—Headache—Prednisone—hematologic cancer	1.38e-05	7.91e-05	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.38e-05	7.89e-05	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.38e-05	0.000285	CbGpPWpGaD
Gadoxetate—Fatigue—Doxorubicin—hematologic cancer	1.37e-05	7.88e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.37e-05	0.000284	CbGpPWpGaD
Gadoxetate—Urticaria—Epirubicin—hematologic cancer	1.37e-05	7.84e-05	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—hematologic cancer	1.36e-05	7.81e-05	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—hematologic cancer	1.36e-05	7.8e-05	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—hematologic cancer	1.36e-05	7.8e-05	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—hematologic cancer	1.36e-05	7.77e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.35e-05	0.000281	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NQO1—hematologic cancer	1.35e-05	0.00028	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CD44—hematologic cancer	1.35e-05	0.00028	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3R1—hematologic cancer	1.34e-05	0.000277	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UGT1A1—hematologic cancer	1.33e-05	0.000275	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.33e-05	0.000275	CbGpPWpGaD
Gadoxetate—Asthenia—Methotrexate—hematologic cancer	1.32e-05	7.57e-05	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—hematologic cancer	1.31e-05	7.53e-05	CcSEcCtD
Gadoxetate—Nausea—Prednisone—hematologic cancer	1.31e-05	7.5e-05	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.3e-05	7.47e-05	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—hematologic cancer	1.3e-05	7.46e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—JAK2—hematologic cancer	1.3e-05	0.000269	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.3e-05	0.000268	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.29e-05	0.000268	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CRABP1—hematologic cancer	1.29e-05	0.000267	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC22A1—hematologic cancer	1.29e-05	0.000267	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.29e-05	0.000267	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYCS—hematologic cancer	1.28e-05	0.000265	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HSP90AA1—hematologic cancer	1.27e-05	0.000264	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Epirubicin—hematologic cancer	1.27e-05	7.27e-05	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—hematologic cancer	1.27e-05	7.26e-05	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—hematologic cancer	1.26e-05	7.22e-05	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—hematologic cancer	1.26e-05	7.22e-05	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—hematologic cancer	1.26e-05	7.22e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—ALOX5—hematologic cancer	1.26e-05	0.000261	CbGpPWpGaD
Gadoxetate—Asthenia—Epirubicin—hematologic cancer	1.24e-05	7.08e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—hematologic cancer	1.23e-05	0.000256	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NQO1—hematologic cancer	1.22e-05	0.000253	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CD44—hematologic cancer	1.22e-05	0.000253	CbGpPWpGaD
Gadoxetate—Pruritus—Epirubicin—hematologic cancer	1.22e-05	6.98e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—NUP98—hematologic cancer	1.22e-05	0.000252	CbGpPWpGaD
Gadoxetate—Dizziness—Methotrexate—hematologic cancer	1.22e-05	6.98e-05	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.21e-05	0.000251	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.2e-05	0.000248	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	1.19e-05	0.000247	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOA3—hematologic cancer	1.18e-05	0.000245	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADCY7—hematologic cancer	1.18e-05	0.000245	CbGpPWpGaD
Gadoxetate—Diarrhoea—Epirubicin—hematologic cancer	1.18e-05	6.75e-05	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—hematologic cancer	1.17e-05	6.73e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—NUP214—hematologic cancer	1.17e-05	0.000243	CbGpPWpGaD
Gadoxetate—Vomiting—Methotrexate—hematologic cancer	1.17e-05	6.71e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.16e-05	0.000241	CbGpPWpGaD
Gadoxetate—Rash—Methotrexate—hematologic cancer	1.16e-05	6.65e-05	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—hematologic cancer	1.16e-05	6.65e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—CYCS—hematologic cancer	1.16e-05	0.000239	CbGpPWpGaD
Gadoxetate—Headache—Methotrexate—hematologic cancer	1.15e-05	6.61e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—ABCG2—hematologic cancer	1.15e-05	0.000238	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTR—hematologic cancer	1.15e-05	0.000238	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HSP90AA1—hematologic cancer	1.15e-05	0.000238	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.14e-05	0.000237	CbGpPWpGaD
Gadoxetate—Asthenia—Doxorubicin—hematologic cancer	1.14e-05	6.55e-05	CcSEcCtD
Gadoxetate—Dizziness—Epirubicin—hematologic cancer	1.14e-05	6.53e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—IL2—hematologic cancer	1.13e-05	0.000235	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTP1—hematologic cancer	1.13e-05	0.000234	CbGpPWpGaD
Gadoxetate—Pruritus—Doxorubicin—hematologic cancer	1.13e-05	6.46e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—ENO2—hematologic cancer	1.13e-05	0.000234	CbGpPWpGaD
Gadoxetate—Vomiting—Epirubicin—hematologic cancer	1.1e-05	6.28e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—GSTT1—hematologic cancer	1.09e-05	0.000227	CbGpPWpGaD
Gadoxetate—Nausea—Methotrexate—hematologic cancer	1.09e-05	6.27e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.09e-05	0.000226	CbGpPWpGaD
Gadoxetate—Diarrhoea—Doxorubicin—hematologic cancer	1.09e-05	6.25e-05	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.09e-05	0.000226	CbGpPWpGaD
Gadoxetate—Rash—Epirubicin—hematologic cancer	1.09e-05	6.22e-05	CcSEcCtD
Gadoxetate—Dermatitis—Epirubicin—hematologic cancer	1.09e-05	6.22e-05	CcSEcCtD
Gadoxetate—Headache—Epirubicin—hematologic cancer	1.08e-05	6.18e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.08e-05	0.000223	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SDC1—hematologic cancer	1.07e-05	0.000222	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—hematologic cancer	1.07e-05	0.000221	CbGpPWpGaD
Gadoxetate—Dizziness—Doxorubicin—hematologic cancer	1.05e-05	6.04e-05	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—NCOR1—hematologic cancer	1.04e-05	0.000215	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—hematologic cancer	1.04e-05	0.000215	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.03e-05	0.000214	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-05	0.000212	CbGpPWpGaD
Gadoxetate—Nausea—Epirubicin—hematologic cancer	1.02e-05	5.86e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.02e-05	0.000212	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.02e-05	0.000212	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTP1—hematologic cancer	1.02e-05	0.000211	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EP300—hematologic cancer	1.02e-05	0.000211	CbGpPWpGaD
Gadoxetate—Vomiting—Doxorubicin—hematologic cancer	1.01e-05	5.81e-05	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.01e-05	0.000209	CbGpPWpGaD
Gadoxetate—Rash—Doxorubicin—hematologic cancer	1.01e-05	5.76e-05	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—hematologic cancer	1e-05	5.75e-05	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—hematologic cancer	9.99e-06	5.72e-05	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—SRC—hematologic cancer	9.89e-06	0.000205	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.85e-06	0.000204	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	9.64e-06	0.0002	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—hematologic cancer	9.64e-06	0.0002	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—hematologic cancer	9.64e-06	0.0002	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.59e-06	0.000199	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—hematologic cancer	9.52e-06	0.000197	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—hematologic cancer	9.47e-06	5.43e-05	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—GSTM1—hematologic cancer	9.36e-06	0.000194	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NCOR1—hematologic cancer	9.36e-06	0.000194	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—hematologic cancer	9.17e-06	0.00019	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK3—hematologic cancer	9.12e-06	0.000189	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NQO1—hematologic cancer	9.09e-06	0.000188	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CD44—hematologic cancer	9.09e-06	0.000188	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.9e-06	0.000184	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—hematologic cancer	8.85e-06	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYCS—hematologic cancer	8.6e-06	0.000178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSP90AA1—hematologic cancer	8.55e-06	0.000177	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—hematologic cancer	8.27e-06	0.000171	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—hematologic cancer	8.19e-06	0.00017	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.08e-06	0.000167	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	7.7e-06	0.00016	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.69e-06	0.000159	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTP1—hematologic cancer	7.58e-06	0.000157	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—hematologic cancer	7.53e-06	0.000156	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.34e-06	0.000152	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.29e-06	0.000151	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—hematologic cancer	7.28e-06	0.000151	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—hematologic cancer	7.18e-06	0.000149	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CREBBP—hematologic cancer	7.14e-06	0.000148	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—hematologic cancer	6.97e-06	0.000144	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOR1—hematologic cancer	6.97e-06	0.000144	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—hematologic cancer	6.96e-06	0.000144	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—hematologic cancer	6.95e-06	0.000144	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	6.77e-06	0.00014	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—hematologic cancer	6.68e-06	0.000139	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CREBBP—hematologic cancer	6.44e-06	0.000134	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	6.39e-06	0.000132	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—hematologic cancer	6.16e-06	0.000128	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—hematologic cancer	6.15e-06	0.000127	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—hematologic cancer	6.11e-06	0.000127	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—hematologic cancer	6.03e-06	0.000125	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	5.9e-06	0.000122	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3R1—hematologic cancer	5.77e-06	0.00012	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.43e-06	0.000112	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—hematologic cancer	5.32e-06	0.00011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	5.17e-06	0.000107	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—hematologic cancer	5.1e-06	0.000106	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—EP300—hematologic cancer	4.86e-06	0.000101	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CREBBP—hematologic cancer	4.8e-06	9.94e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—hematologic cancer	4.6e-06	9.54e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	4.55e-06	9.43e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—hematologic cancer	4.49e-06	9.31e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—EP300—hematologic cancer	4.39e-06	9.09e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	4.3e-06	8.9e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	3.96e-06	8.22e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	3.6e-06	7.46e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—hematologic cancer	3.43e-06	7.1e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—EP300—hematologic cancer	3.27e-06	6.77e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—hematologic cancer	3.25e-06	6.73e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—hematologic cancer	2.94e-06	6.09e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—hematologic cancer	2.65e-06	5.5e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.42e-06	5.01e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.97e-06	4.09e-05	CbGpPWpGaD
